# US 2002/0053915 A1 · Electrophysiology configuration suitable for high throughput screening of compounds for drug discovery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0053915 A1
- Document ID: US20020053915A1
- Status: Published application
- Kind: A1
- Application number: 09/900,627
- Filed: 2001-07-06
- Published: 2002-05-09
- Earliest claimed: 2000-07-07
- Inventors: Charles David Weaver; Alastair Binnie
- Web page: https://patentgrep.com/patent/US20020053915A1

## CPC

- G01N 33/5008: {for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics}
- G01N 33/48728: {Investigating individual cells, e.g. by patch clamp, voltage clamp (investigating individual particles in general G01N15/10)}
- G01N 2500/10: involving cells
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides apparatuses for measuring cell membrane resistance, conductance, potential, and capacitance, which can be used to determine cellular electrical activity. More specifically, the present invention provides automated apparatuses that are designed for high-throughput analysis of various compounds, ligands, and cell processes that modulate cellular electrical properties (e.g., cell membrane conditions). Such automated apparatuses can be used for the precise determination of ion channel activity, and for the rapid identification of compounds, ligands, or processes that alter this activity. The present invention also provides methods for measuring cellular electrical properties utilizing the apparatuses provided herein.

## Claims

### Claim 1

An apparatus for measuring cellular electrical conditions comprising a Cell Support Membrane component adapted to hold one or more cells which includes: i) a first layer comprising a non-conductive material comprising a top surface and bottom surface and including one or more pores, wherein the top surface of the material comprises one or more cell attachment sites which circumscribe the pores of the material and contact the cells, and wherein the pores of the material are capable of forming electrically tight seals with the contacted cells at the cell attachment sites, and ii) a second layer comprising a non-porous, nonconductive, sealant material which contacts the first layer of the Cell Support Membrane.

### Claim 2 (depends on 1)

The apparatus according to claim 1, wherein the cellular electrical conditions are selected from the group consisting of transmembrane potential, capacitance, resistance, and conductance.

### Claim 3 (depends on 1)

The apparatus according to claim 1, wherein the first layer of the Cell Support Membrane component comprises material selected from the group consisting of glass, plastic, rubber, polytetraflurotethylene, polytetraflurotethylene/glass, polyethylene terephthalate, and polycarbonate.

### Claim 4 (depends on 1)

The apparatus according to claim 1, wherein the second layer of the Cell Support Membrane component comprises material selected from the group consisting of polytetraflurotethylene, polytetraflurotethylene/glass, polyethylene terephthalate, and polycarbonate.

### Claim 5 (depends on 1)

The apparatus according to claim 1, wherein the second layer of the Cell Support Membrane component comprises material selected from the group consisting of polyhydroxybutyrate, polylactate, polyglycolic acid, polycaprolactone, cellulose, starch, and collagen.

### Claim 6 (depends on 1)

The apparatus according to claim 1, wherein the second layer of the Cell Support Membrane component comprises a dye.

### Claim 7 (depends on 6)

The apparatus according to claim 6, wherein the second layer of the Cell Support Membrane component comprises Solvent Blue 14.

### Claim 8 (depends on 1)

The apparatus according to claim 1, wherein the cell attachment sites of the first layer of the Cell Support Membrane component are treated with a composition comprising molecules that facilitate cell attachment.

### Claim 9 (depends on 8)

The apparatus according to claim 8, wherein the molecules are selected from the group consisting of gelatin, poly-L-lysine, poly-D-lysine, collagen, and fibronectin.

### Claim 10 (depends on 1)

The apparatus according to claim 1, wherein an area of the first layer of the Cell Support Membrane component outside of the cell attachment sites is treated with a composition comprising molecules that inhibit cell attachment.

### Claim 11 (depends on 10)

The apparatus according to claim 10, wherein the molecules are selected from the group consisting of silane, silicone, and Teflon®.

### Claim 12 (depends on 1)

The apparatus according to claim 1, wherein the first layer of the Cell Support Membrane component displays at least 4 pores.

### Claim 13 (depends on 1)

The apparatus according to claim 1, wherein the first layer of the Cell Support Membrane component displays 1 pore.

### Claim 14 (depends on 1)

The apparatus according to claim 1, wherein the pores of the first layer of the Cell Support Membrane component are between 0.2 μm and 2 μm in diameter.

### Claim 15 (depends on 1)

The apparatus according to claim 1, wherein the cells are selected from the group consisting of HEK-293 cells, Chinese hamster ovary cells, primary neuronal cells, skeletal muscle cells, smooth muscle cells, cardiac muscle cells, immune cells, epithelial cells, and endothelial cells.

### Claim 16 (depends on 15)

The apparatus according to claim 15, wherein the primary neuronal cells are selected from the group consisting of hippocampus, dorsal root ganglia, and superior cervical ganglia cells.

### Claim 17 (depends on 1)

The apparatus according to claim 1, wherein the cells comprise DNA constructs directing the expression of molecules selected from the group consisting of ion channel proteins, ion transporters, G-proteins, G-protein ligands, G-protein modulators, G-protein receptors, protein kinases, and protein phosphatases.

### Claim 18 (depends on 1)

The apparatus according to claim 1, wherein the cells express ion channels that are specific for ions selected from the group consisting of sodium, potassium, calcium, and chloride.

### Claim 19 (depends on 1)

The apparatus according to claim 1, wherein the cells are permeabilized by contact with any one of the following: i) an antibiotic selected from the group consisting of amphotericin and nystatin; ii) a detergent selected from the group consisting of digitonin and saponin; or iii) a high voltage field.

### Claim 20 (depends on 1)

The apparatus according to claim 1, wherein the second layer is positioned under the first layer of the Cell Support Membrane component, and an area of the second layer of the Cell Support Membrane component that is in contact with a pore that is contacted with a cell is selectively removed.

### Claim 21 (depends on 20)

The apparatus according to claim 20, wherein the area of the second layer of the Cell Support Membrane component is removed by microscope-assisted photo-ablation.

### Claim 22 (depends on 21)

The apparatus according to claim 21, wherein the microscope is a confocal microscope.

### Claim 23 (depends on 21)

The apparatus according to claim 21, wherein the photo-ablation is carried out with a flash lamp.

### Claim 24 (depends on 21)

The apparatus according to claim 21, wherein the photo-ablation is carried out with a laser.

### Claim 25 (depends on 24)

The apparatus according to claim 24, wherein the laser is selected from the group consisting of argon, helium/neon, krypton, YAG, and titanium-sapphire laser.

### Claim 26 (depends on 1)

The apparatus according to claim 1, wherein the second layer is positioned over the first layer of the Cell Support Membrane component, and an area of the second layer of the Cell Support Membrane component that is in contact with a pore that is contacted with a cell is selectively removed.

### Claim 27 (depends on 26)

The apparatus according to claim 26, wherein the area of the second layer of the Cell Support Membrane component is removed by an enzyme selected from the group consisting of proteases, cellulases, esterases, and depolymerases, which is secreted by the cell.

### Claim 28 (depends on 1)

The apparatus according to claim 1, further comprising a chamber to hold the Cell Support Membrane component which includes a top area and bottom area, wherein the cell attachment sites of the Cell Support Membrane component face the top area of the chamber.

### Claim 29 (depends on 28)

The apparatus according to claim 28, further comprising electrolyte solution which contacts the first and second layers of the Cell Support Membrane component.

### Claim 30 (depends on 29)

The apparatus according to claim 29, further comprising two electrodes, Electrode 1 and Electrode 2, that are placed in the electrolyte solution, wherein one Electrode 1 is a ‘ground’ electrode and Electrode 2 is a current-passing/voltage-measuring electrode, and wherein one of the two electrodes faces the top surface of the first layer of the Cell Support Membrane component, and one of the two electrode faces the bottom surface of the first layer of the Cell Support Membrane component.

### Claim 31 (depends on 30)

The apparatus according to claim 30, further comprising local pre-amplification circuitry, and a voltage-clamp, current-clamp and lock-in amplifier.

### Claim 32

An apparatus for measuring cellular electrical conditions comprising a Cell Support Membrane component adapted to hold one or more cells which comprises a non-conductive material that includes a top surface and bottom surface and includes one or more pores, wherein: i) the top surface of the material comprises one or more cell attachment sites which circumscribe the pores of the material and contact the cells; ii) the pores of the material are capable of forming electrically tight seals with the contacted cells at the cell attachment sites, and iii) a pore that is not sealed with a cell is plugged by the addition of one composition to the top surface of the material, and another composition to the bottom surface of the material, such that the compositions interact in the pore and form a nonconductive solid product.

### Claim 33 (depends on 32)

The apparatus according to claim 32, wherein the cellular electrical conditions are selected from the group consisting of transmembrane potential, capacitance, resistance, and conductance.

### Claim 34 (depends on 32)

The apparatus according to claim 32, wherein the one composition comprises an enzyme and the other composition comprises a substrate for the enzyme.

### Claim 35 (depends on 32)

The apparatus according to claim 32, wherein the one composition comprises calf alkaline phosphatase and the other composition comprises 5-bromo-4-chloro-3′-indolyphosphate p-toluidine salt and nitro-blue tetrazolium.

### Claim 36 (depends on 32)

The apparatus according to claim 32, wherein the material comprising the Cell Support Membrane component is selected from the group consisting of glass, plastic, rubber, polytetraflurotethylene, polytetraflurotethylene/glass, polyethylene terephthalate, and polycarbonate.

### Claim 37 (depends on 32)

The apparatus according to claim 32, wherein the cell attachment sites of the Cell Support Membrane component are treated with a composition comprising molecules that facilitate cell attachment.

### Claim 38 (depends on 37)

The apparatus according to claim 37, wherein the molecules are selected from the group consisting of gelatin, poly-L-lysine, poly-D-lysine, collagen, and fibronectin.

### Claim 39 (depends on 32)

The apparatus according to claim 32, wherein an area outside of the cell attachment site is treated with a composition comprising molecules that inhibit cell attachment.

### Claim 40 (depends on 39)

The apparatus according to claim 39, wherein the molecules are selected from the group consisting of silane, silicone, and Teflon®.

### Claim 41 (depends on 32)

The apparatus according to claim 32, wherein the Cell Support Membrane component displays at least 4 pores.

### Claim 42 (depends on 32)

The apparatus according to claim 32, wherein the Cell Support Membrane component displays 1 pore.

### Claim 43 (depends on 32)

The apparatus according to claim 32, wherein the pores are between 0.2 μm and 2 μm in diameter.

### Claim 44 (depends on 32)

The apparatus according to claim 32, wherein the cells are selected from the group consisting of HEK-293 cells, Chinese hamster ovary cells, primary neuronal cells, skeletal muscle cells, smooth muscle cells, cardiac muscle cells, immune cells, epithelial cells, and endothelial cells.

### Claim 45 (depends on 44)

The apparatus according to claim 44, wherein the primary neuronal cells are selected from the group consisting of hippocampus, dorsal root ganglia, and superior cervical ganglia cells.

### Claim 46 (depends on 32)

The apparatus according to claim 32, wherein the cells comprise DNA constructs directing the expression of molecules selected from the group consisting of ion channel proteins, ion transporters, G-proteins, G-protein ligands, G-protein modulators, G-protein receptors, membrane receptors, protein kinases, and protein phosphatases.

### Claim 47 (depends on 32)

The apparatus according to claim 32, wherein the cells express ion channels that are specific for ions selected from the group consisting of sodium, potassium, calcium, and chloride.

### Claim 48 (depends on 32)

The apparatus according to claim 32, wherein the cells are permeabilized by contact with any one of the following: i) an antibiotic selected from the group consisting of amphotericin and nystatin; ii) a detergent selected from the group consisting of digitonin and saponin; or iii) a high voltage field.

### Claim 49 (depends on 32)

The apparatus according to claim 32 , further comprising a chamber to hold the Cell Support Membrane component which includes a top area and bottom area, wherein the Cell Support Membrane component is positioned in the chamber so that the cell attachment sites of the Cell Support Membrane face the top area of the chamber.

### Claim 50 (depends on 49)

The apparatus according to claim 49, further comprising electrolyte solution which contacts the first and second layers of the Cell Support Membrane component.

### Claim 51 (depends on 50)

The apparatus according to claim 50, further comprising two electrodes, Electrode 1 and Electrode 2, that are placed in the electrolyte solution, wherein one Electrode 1 is a ‘ground’ electrode and Electrode 2 is a current-passing/voltage-measuring electrode, and wherein one of the two electrodes faces the top surface of the first layer of the Cell Support Membrane component, and one of the two electrode faces the bottom surface of the first layer of the Cell Support Membrane component.

### Claim 52 (depends on 51)

The apparatus according to claim 51, further comprising pre-amplification circuitry and a voltage-clamp, current-clamp and lock-in amplifier.

### Claim 53

An apparatus for measuring cellular electrical conditions comprising a Cell Support Membrane component adapted to hold cells which comprises a non-conductive material including a top surface and bottom surface and including one or more pores, wherein: i) the top surface of the material comprises one or more cell attachment sites which circumscribe the pores of the material and contact the cells; ii) the pores of the material are capable of forming electrically tight seals with the contacted cells at the cell attachment sites, and iii) the cells are directed to the pores by an attractant.

### Claim 54 (depends on 53)

The apparatus according to claim 53, wherein the cellular electrical conditions are selected from the group consisting of transmembrane potential, capacitance, resistance, and conductance.

### Claim 55 (depends on 53)

The apparatus according to claim 53, wherein the attractant is a chemoattractant.

### Claim 56 (depends on 55)

The apparatus according to claim 55, wherein the chemoattractant is selected from the group consisting of growth factors, chemokines, and nutrients.

### Claim 57 (depends on 56)

The apparatus according to claim 56, wherein the chemoattractant is 20-hydroxyleukotrine B4.

### Claim 58 (depends on 53)

The apparatus according to claim 53, wherein the attractant is an electric field.

### Claim 59 (depends on 53)

The apparatus according to claim 53, wherein the cells are resuspended in a density gradient.

### Claim 60 (depends on 59)

The apparatus according to claim 59, wherein the density gradient comprises suspensions selected from the group consisting of percoll, ficoll, and metrizamide.

### Claim 61 (depends on 53)

The apparatus according to claim 53, wherein the material comprising the Cell Support Membrane component is selected from the group consisting of glass, plastic, rubber, polytetraflurotethylene, polytetraflurotethylene/glass, polyethylene terephthalate, and polycarbonate.

### Claim 62 (depends on 53)

The apparatus according to claim 53, wherein the cell attachment sites of the Cell Support Membrane component are treated with a composition comprising molecules that facilitate cell attachment.

### Claim 63 (depends on 62)

The apparatus according to claim 62, wherein the molecules are selected from the group consisting of gelatin, poly-L-lysine, poly-D-lysine, collagen, and fibronectin.

### Claim 64 (depends on 53)

The apparatus according to claim 53, wherein an area outside of the cell attachment sites is treated with a composition comprising molecules that inhibit cell attachment.

### Claim 65 (depends on 64)

The apparatus according to claim 64, wherein the molecules are selected from the group consisting of silane, silicone, and Teflon®.

### Claim 66 (depends on 53)

The apparatus according to claim 53, wherein the Cell Support Membrane component displays at least 4 pores.

### Claim 67 (depends on 53)

The apparatus according to claim 53, wherein the Cell Support Membrane component displays 1 pore.

### Claim 68 (depends on 53)

The apparatus according to claim 53, wherein the pores are between 0.2 μm and 2 μm in diameter.

### Claim 69 (depends on 53)

The apparatus according to claim 53, wherein the cells are selected from the group consisting of HEK-293 cells, Chinese hamster ovary cells, primary neuronal cells, skeletal muscle cells, smooth muscle cells, cardiac muscle cells, immune cells, epithelial cells, and endothelial cells.

### Claim 70 (depends on 69)

The apparatus according to claim 69, wherein the primary neuronal cells are selected from the group consisting of hippocampus, dorsal root ganglia, and superior cervical ganglia cells.

### Claim 71 (depends on 53)

The apparatus according to claim 53, wherein the cells comprise DNA constructs directing the expression of molecules selected from the group consisting of ion channel proteins, ion transporters, G-proteins, G-protein ligands, G-protein modulators, G-protein receptors, membrane receptors, protein kinases, and protein phosphatases.

### Claim 72 (depends on 53)

The apparatus according to claim 53, wherein the cells express ion channels that are specific for ions selected from the group consisting of sodium, potassium, calcium, and chloride.

### Claim 73 (depends on 53)

The apparatus according to claim 53, wherein the cells are permeabilized by contact with any one of the following: i) an antibiotic selected from the group consisting of amphotericin and nystatin; ii) a detergent selected from the group consisting of digitonin and saponin; or iii) a high voltage field.

### Claim 74 (depends on 53)

The apparatus according to claim 53, further comprising a chamber to hold the Cell Support Membrane component which includes a top area and bottom area, wherein the Cell Support Membrane component is positioned in the chamber so that the cell attachment sites of the Cell Support Membrane face the top area of the chamber.

### Claim 75 (depends on 74)

The apparatus according to claim 74, further comprising electrolyte solution placed in the chamber to contact the first and second layers of the Cell Support Membrane component.

### Claim 76 (depends on 75)

The apparatus according to claim 75, further comprising two electrodes, Electrode 1 and Electrode 2, that are placed in the electrolyte solution, wherein one Electrode 1 is a ‘ground’ electrode and Electrode 2 is a current-passing/voltage-measuring electrode, and wherein one of the two electrodes faces the top surface of the first layer of the Cell Support Membrane component, and one of the two electrode faces the bottom surface of the first layer of the Cell Support Membrane component.

### Claim 77 (depends on 76)

The apparatus according to claim 76, further comprising pre-amplification circuitry and a voltage-clamp, current-clamp and lock-in amplifier.

### Claim 78

An apparatus for measuring cellular electrical conditions comprising a Microchip component adapted to hold cells which comprises non-conductive material including a top surface and bottom surface, wherein the top surface of the material includes cell attachment sites that are sized to contact individual cells and are coupled to an electrode lead/signal modifying circuitry.

### Claim 79 (depends on 78)

The apparatus according to claim 78, wherein the cellular electrical conditions are selected from the group consisting of transmembrane potential, capacitance, resistance, and conductance.

### Claim 80 (depends on 78)

The apparatus according to claim 78, wherein the material of the Microarray component is selected from the group consisting of glass, silicone, plastic, rubber, polytetraflurotethylene, polytetraflurotethylene/glass, polyethylene terephthalate, and polycarbonate.

### Claim 81 (depends on 78)

The apparatus according to claim 78, wherein the cell attachment sites are treated with a composition comprising molecules that facilitate cell attachment.

### Claim 82 (depends on 81)

The apparatus according to claim 81, wherein the molecules are selected from the group consisting of gelatin, poly-L-lysine, poly-D-lysine, collagen, and fibronectin.

### Claim 83 (depends on 78)

The apparatus according to claim 78, wherein an area surrounding the cell attachment sites is treated with a composition comprising molecules that inhibit cell attachment.

### Claim 84 (depends on 83)

The apparatus according to claim 83, wherein the molecules are selected from the group consisting of silane, silicone, and Teflon®.

### Claim 85 (depends on 78)

The apparatus according to claim 78, wherein the cell attachment sites include pins that are sized to penetrate the contacting cell, and wherein each pin houses an electrode connected to a headstage preamplifier.

### Claim 86 (depends on 78)

The apparatus according to claim 78, wherein the cell attachment sites include pits that are sized to accommodate the contacting cells.

### Claim 87 (depends on 78)

The apparatus according to claim 78, wherein the top surface of the Microchip component displays at least 9 cell attachment sites.

### Claim 88 (depends on 78)

The apparatus according to claim 78, wherein the cell attachment sites are between 15 μm and 20 μm in diameter.

### Claim 89 (depends on 78)

The apparatus according to claim 78, wherein the cells are selected from the group consisting of HEK-293 cells, Chinese hamster ovary cells, primary neuronal cells, skeletal muscle cells, smooth muscle cells, cardiac muscle cells, immune cells, epithelial cells, and endothelial cells.

### Claim 90 (depends on 89)

The apparatus according to claim 89, wherein the primary neuronal cells are selected from the group consisting of hippocampus, dorsal root ganglia, and superior cervical ganglia cells.

### Claim 91 (depends on 78)

The apparatus according to claim 78, wherein the cells comprise DNA constructs directing the expression of molecules selected from the group consisting of ion channel proteins, ion transporters, G-proteins, G-protein ligands, G-protein modulators, G-protein receptors, membrane receptors, protein kinases, and protein phosphatases.

### Claim 92 (depends on 78)

The apparatus according to claim 78, wherein the cells express ion channels that are specific for ions selected from the group consisting of sodium, potassium, calcium, and chloride.

### Claim 93 (depends on 78)

The apparatus according to claim 78, wherein the cells are permeabilized by contact with a high voltage field.

### Claim 94 (depends on 78)

The apparatus according to claim 78, wherein a cell attachment site is adjacent to an independent ground electrode and connected to an independent measuring electrode.

### Claim 95 (depends on 78)

The apparatus according to claim 78, further comprising a chamber to hold the Cell Support Membrane component which includes a top area and bottom area, wherein the Microchip component is positioned in the chamber so that the cell attachment sites of the Microchip face the top area of the chamber.

### Claim 96 (depends on 95)

The apparatus according to claim 95, further comprising electrolyte solution which contacts the top surface of the Microchip component.

### Claim 97 (depends on 96)

The apparatus according to claim 96, further comprising local pre-amplification circuitry and a voltage-clamp, current-clamp, and lock-in amplifier.

### Claim 98 (depends on 31)

An high throughput screening method for detecting and assaying test agents that affect cellular electrical activity comprising: i) attaching cells to a plurality of apparatuses according to claim 31; ii) measuring electrical activity of the cells contacted with electrolyte solution; iii) contacting the cells with an electrolyte solution comprising a test agent; iv) measuring the electrical activity of the cells contacted with the test agent; and v) assessing a difference between the measured electrical activity in step (ii) and the measured electrical activity in step (iv).

### Claim 99 (depends on 98)

The method according to claim 98, wherein the cellular electrical activity is selected from the group consisting of potential, resistance, conductance, and capacitance.

### Claim 100 (depends on 98)

The method according to claim 98, wherein chambers of the apparatuses are provided by a multi-well plate.

### Claim 101 (depends on 98)

The method according to claim 98, wherein the multi-well plate is processed by computer-controlled equipment.

### Claim 102 (depends on 98)

The method according to claim 98, wherein the cells are selected from the group consisting of HEK-293 cells, Chinese hamster ovary cells, primary neuronal cells, skeletal muscle cells, smooth muscle cells, cardiac muscle cells, immune cells, epithelial cells, and endothelial cells.

### Claim 103 (depends on 102)

The method according to claim 102, wherein the primary neuronal cells are selected from the group consisting of hippocampus, dorsal root ganglia, and superior cervical ganglia cells.

### Claim 104 (depends on 98)

The method according to claim 98, wherein the cells comprise DNA constructs directing the expression of molecules selected from the group consisting of ion channel proteins, ion transporters, G-proteins, G-protein ligands, G-protein modulators, G-protein receptors, membrane receptors, protein kinases, and protein phosphatases.

### Claim 105 (depends on 98)

The method according to claim 98, wherein the cells express ion channels that are specific for ions selected from the group consisting of sodium, potassium, calcium, and chloride.

### Claim 106 (depends on 98)

The method according to claim 98, wherein the cells are permeabilized by contact with any one of the following: i) an antibiotic selected from the group consisting of amphotericin and nystatin; ii) a detergent selected from the group consisting of digitonin and saponin; and iii) a high voltage field.

### Claim 107 (depends on 98)

The method according to claim 98, wherein the test agent is selected from the group consisting of neurotransmitters, neurotransmitter analogues, enzyme inhibitors, ion channel modulators, G-proteins, G-protein ligands, G-protein modulators, G-protein receptors, transport inhibitors, hormones, peptides, toxins, antibodies, pharmaceutical agents, and chemicals.

### Claim 108 (depends on 98)

The method according to claim 98, wherein the test agent is selected from the group consisting of purinergics, cholinergics, serotonergics, dopaminergics, anesthetics, benzodiazepines, barbiturates, steroids, alcohols, metal cations, cannabinoids, cholecystokinins, cytokines, excitatory amino acids, GABAergics, gangliosides, histaminergics, melatonins, neuropeptides, neurotoxins, endothelins, NO compounds, opioids, sigma receptor ligands, somatostatins, tachykinins, angiotensins, bombesins, bradykinins, and prostaglandins.

### Claim 109 (depends on 31)

A high throughput screening method for detecting and assaying cell processes that affect cellular electrical activity comprising: i) attaching cells to a plurality of apparatuses according to claim 31; ii) measuring electrical activity of cells that are in a resting state; iii) initiating the cell process; iv) measuring the electrical activity of cells engaged in the process; and v) assessing a difference between the measured electrical activity in step (ii) and the measured electrical activity in step (iv).

### Claim 110 (depends on 109)

The method according to claim 109, wherein the cellular electrical activity is selected from the group consisting of potential, resistance, conductance, and capacitance.

### Claim 111 (depends on 109)

The method according to claim 109, wherein chambers of the apparatuses are provided by a multi-well plate.

### Claim 112 (depends on 109)

The method according to claim 109, wherein the multi-well plate is processed by computer-controlled equipment.

### Claim 113 (depends on 109)

The method according to claim 109, wherein the cells are selected from the group consisting of HEK-293 cells, Chinese hamster ovary (CHO) cells, primary neuronal cells, skeletal muscle cells, smooth muscle cells, cardiac muscle cells, immune cells; epithelial cells, and endothelial cells.

### Claim 114 (depends on 113)

The method according to claim 113, wherein the primary neuronal cells are selected from the group consisting of hippocampus, dorsal root ganglia, and superior cervical ganglia cells.

### Claim 115 (depends on 109)

The method according to claim 109, wherein the cells comprise DNA constructs directing the expression of molecules selected from the group consisting of ion channel proteins, ion transporters, G-protein coupled receptors, membrane receptors, protein kinases, and protein phosphatases.

### Claim 116 (depends on 109)

The method according to claim 109, wherein the cells express ion channels that are specific for ions selected from the group consisting of sodium, potassium, calcium, and chloride.

### Claim 117 (depends on 109)

The method according to claim 109, wherein the cells are permeabilized by contact with any one of the following: i) an antibiotic selected from the group consisting of amphotericin and nystatin; ii) a detergent selected from the group consisting of digitonin and saponin; and iii) a high voltage field.

### Claim 118 (depends on 109)

The method according to claim 109, wherein the test agent is selected from the group consisting of neurotransmitters, neurotransmitter analogues, enzyme inhibitors, ion channel modulators, G-proteins, G-protein ligands, G-protein modulators, G-protein receptors, transport inhibitors, hormones, peptides, toxins, antibodies, pharmaceutical agents, and chemicals.

### Claim 119 (depends on 109)

The method according to claim 109, wherein the test agent is selected from the group consisting of purinergics, cholinergics, serotonergics, dopaminergics, anesthetics, benzodiazepines, barbiturates, steroids, alcohols, metal cations, cannabinoids, cholecystokinins, cytokines, excitatory amino acids, GABAergics, gangliosides, histaminergics, melatonins, neuropeptides, neurotoxins, endothelins, NO compounds, opioids, sigma receptor ligands, somatostatins, tachykinins, angiotensins, bombesins, bradykinins, and prostaglandins.

### Claim 120 (depends on 109)

The method according to claim 109, wherein the cell process is selected from the group consisting of cell-cell interaction, cell-cell fusion, viral infection, endocytosis, exocytosis, membrane recycling, and membrane-ligand interaction.
